Est especialmente indicado para personas expuestas a factores de estrs oxidativo como la contaminacin, el tabaco, el estrs, el alcohol o los rayos UV
Meanwhile, at Novo Nordisk, the most valuable European company thanks to its anti-obesity drugs, they are testing a range of drugs, including Cagrisema, which combines GLP-1 with an analog of amylin, a hormone that slows gastric emptying and reduces appetite
This increases production and compliance costs, making it a barrier, particularly for small and medium-sized manufacturers
It promotes protein synthesis, reduces muscle breakdown, and directs the body to prioritize fat stores for energy
At the same time, if access to and insurance coverage for these medications continue to grow, it could open the door for more people to get treatment for substance use